First report of ibrutinib in IgM-related amyloidosis: few responses, poor tolerability, and short survival
TO THE EDITOR: Light-chain amyloidosis (AL) is a rare systemic protein deposition disorder that belongs to the group of plasma cell dyscrasias. Approximately 10% to 22% of cases are associated with symptomatic multiple myeloma or Waldenström macroglobulinemia (WM). The disease is characterized by
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2018
|
| In: |
Blood
Year: 2018, Jahrgang: 131, Heft: 3, Pages: 368-371 |
| ISSN: | 1528-0020 |
| DOI: | 10.1182/blood-2017-09-806463 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1182/blood-2017-09-806463 Verlag, Volltext: http://www.bloodjournal.org/content/131/3/368 
|
| Verfasserangaben: | Tomas Pika, Ute Hegenbart, Pavla Flodrova, Bettina Maier, Christoph Kimmich, Stefan O. Schönland |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1581501714 | ||
| 003 | DE-627 | ||
| 005 | 20220815023151.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181002s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1182/blood-2017-09-806463 |2 doi | |
| 035 | |a (DE-627)1581501714 | ||
| 035 | |a (DE-576)511501714 | ||
| 035 | |a (DE-599)BSZ511501714 | ||
| 035 | |a (OCoLC)1341019569 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Pica, Tomas |e VerfasserIn |0 (DE-588)1168277736 |0 (DE-627)1031930884 |0 (DE-576)511500785 |4 aut | |
| 245 | 1 | 0 | |a First report of ibrutinib in IgM-related amyloidosis |b few responses, poor tolerability, and short survival |c Tomas Pika, Ute Hegenbart, Pavla Flodrova, Bettina Maier, Christoph Kimmich, Stefan O. Schönland |
| 264 | 1 | |c 2018 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a First edition: November 27, 2017 | ||
| 500 | |a Gesehen am 02.10.2018 | ||
| 520 | |a TO THE EDITOR: Light-chain amyloidosis (AL) is a rare systemic protein deposition disorder that belongs to the group of plasma cell dyscrasias. Approximately 10% to 22% of cases are associated with symptomatic multiple myeloma or Waldenström macroglobulinemia (WM). The disease is characterized by | ||
| 700 | 1 | |a Hegenbart, Ute |e VerfasserIn |0 (DE-588)1028373708 |0 (DE-627)73062157X |0 (DE-576)35901903X |4 aut | |
| 700 | 1 | |a Maier, Bettina |e VerfasserIn |0 (DE-588)136408214 |0 (DE-627)582080452 |0 (DE-576)301004498 |4 aut | |
| 700 | 1 | |a Kimmich, Christoph |e VerfasserIn |0 (DE-588)1075478413 |0 (DE-627)833305042 |0 (DE-576)443499632 |4 aut | |
| 700 | 1 | |a Schönland, Stefan |d 1969- |e VerfasserIn |0 (DE-588)122405226 |0 (DE-627)705896137 |0 (DE-576)293255792 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood |d Washington, DC : American Society of Hematology, 1946 |g 131(2018), 3, Seite 368-371 |h Online-Ressource |w (DE-627)266886647 |w (DE-600)1468538-3 |w (DE-576)075961938 |x 1528-0020 |7 nnas |a First report of ibrutinib in IgM-related amyloidosis few responses, poor tolerability, and short survival |
| 773 | 1 | 8 | |g volume:131 |g year:2018 |g number:3 |g pages:368-371 |g extent:4 |a First report of ibrutinib in IgM-related amyloidosis few responses, poor tolerability, and short survival |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1182/blood-2017-09-806463 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.bloodjournal.org/content/131/3/368 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20181002 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 122405226 |a Schönland, Stefan |m 122405226:Schönland, Stefan |d 910000 |d 910100 |e 910000PS122405226 |e 910100PS122405226 |k 0/910000/ |k 1/910000/910100/ |p 6 |y j | ||
| 998 | |g 1075478413 |a Kimmich, Christoph |m 1075478413:Kimmich, Christoph |d 910000 |d 910100 |e 910000PK1075478413 |e 910100PK1075478413 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 998 | |g 136408214 |a Maier, Bettina |m 136408214:Maier, Bettina |d 910000 |d 910100 |e 910000PM136408214 |e 910100PM136408214 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 1028373708 |a Hegenbart, Ute |m 1028373708:Hegenbart, Ute |d 910000 |d 910100 |e 910000PH1028373708 |e 910100PH1028373708 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 999 | |a KXP-PPN1581501714 |e 302760080X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"given":"Tomas","family":"Pica","role":"aut","roleDisplay":"VerfasserIn","display":"Pica, Tomas"},{"given":"Ute","family":"Hegenbart","role":"aut","roleDisplay":"VerfasserIn","display":"Hegenbart, Ute"},{"roleDisplay":"VerfasserIn","display":"Maier, Bettina","role":"aut","family":"Maier","given":"Bettina"},{"given":"Christoph","family":"Kimmich","role":"aut","roleDisplay":"VerfasserIn","display":"Kimmich, Christoph"},{"family":"Schönland","given":"Stefan","display":"Schönland, Stefan","roleDisplay":"VerfasserIn","role":"aut"}],"title":[{"subtitle":"few responses, poor tolerability, and short survival","title":"First report of ibrutinib in IgM-related amyloidosis","title_sort":"First report of ibrutinib in IgM-related amyloidosis"}],"recId":"1581501714","language":["eng"],"note":["First edition: November 27, 2017","Gesehen am 02.10.2018"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Tomas Pika, Ute Hegenbart, Pavla Flodrova, Bettina Maier, Christoph Kimmich, Stefan O. Schönland"]},"id":{"doi":["10.1182/blood-2017-09-806463"],"eki":["1581501714"]},"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"2018"}],"relHost":[{"origin":[{"publisher":"American Society of Hematology ; Saunders ; HighWire Press","dateIssuedKey":"1946","dateIssuedDisp":"1946-","publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif."}],"id":{"issn":["1528-0020"],"eki":["266886647"],"zdb":["1468538-3"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Blood","subtitle":"journal of the American Society of Hematology","title":"Blood"}],"disp":"First report of ibrutinib in IgM-related amyloidosis few responses, poor tolerability, and short survivalBlood","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 21.04.2023"],"recId":"266886647","language":["eng"],"corporate":[{"roleDisplay":"Herausgebendes Organ","display":"American Society of Hematology","role":"isb"}],"pubHistory":["1.1946 -"],"part":{"pages":"368-371","issue":"3","year":"2018","extent":"4","text":"131(2018), 3, Seite 368-371","volume":"131"},"titleAlt":[{"title":"Blood online"}]}],"physDesc":[{"extent":"4 S."}]} | ||
| SRT | |a PICATOMASHFIRSTREPOR2018 | ||